Lv4
520 积分 2021-12-10 加入
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase–Deficient Renal Cell Carcinoma
11天前
已完结
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer
11天前
已完结
Molecular and therapeutic landscape of non-clear cell renal carcinoma
11天前
已完结
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture
21天前
已完结
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials
1个月前
已完结
Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial
3个月前
已完结
Abiraterone Acetate–Associated Acute Pancreatitis: A Case Report
3个月前
已完结
Cancer statistics, 2026: divergent trends and the implementation gap
3个月前
已完结
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical Prostatectomy
4个月前
已完结
Field-effect-informed urine liquid biopsy for bladder cancer
5个月前
已完结
皖公网安备34019202002308
